ID   PAR2_RAT                Reviewed;         397 AA.
AC   Q63645; Q499T9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 169.
DE   RecName: Full=Proteinase-activated receptor 2;
DE            Short=PAR-2;
DE   AltName: Full=Coagulation factor II receptor-like 1;
DE   AltName: Full=Thrombin receptor-like 1;
DE   Flags: Precursor;
GN   Name=F2rl1; Synonyms=Par2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Intestine, and Kidney;
RX   PubMed=8762073; DOI=10.1111/j.1476-5381.1996.tb15433.x;
RA   Saifeddine M., Al-Ani B., Cheng C.H., Wang L., Hollenberg M.D.;
RT   "Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of
RT   receptor-derived peptides in gastric and vascular tissue.";
RL   Br. J. Pharmacol. 118:521-530(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION.
RX   PubMed=11884377; DOI=10.1161/hh0402.105372;
RA   McLean P.G., Aston D., Sarkar D., Ahluwalia A.;
RT   "Protease-activated receptor-2 activation causes EDHF-like coronary
RT   vasodilation: selective preservation in ischemia/reperfusion injury:
RT   involvement of lipoxygenase products, VR1 receptors, and C-fibers.";
RL   Circ. Res. 90:465-472(2002).
RN   [4]
RP   INTERACTION WITH TMED2.
RX   PubMed=17693410; DOI=10.1074/jbc.m703205200;
RA   Luo W., Wang Y., Reiser G.;
RT   "p24A, a type I transmembrane protein, controls ARF1-dependent
RT   resensitization of protease-activated receptor-2 by influence on receptor
RT   trafficking.";
RL   J. Biol. Chem. 282:30246-30255(2007).
CC   -!- FUNCTION: Receptor for trypsin and trypsin-like enzymes coupled to G
CC       proteins. Its function is mediated through the activation of several
CC       signaling pathways including phospholipase C (PLC), intracellular
CC       calcium, mitogen-activated protein kinase (MAPK), I-kappaB kinase/NF-
CC       kappaB and Rho. Can also be transactivated by cleaved F2R/PAR1.
CC       Involved in modulation of inflammatory responses and regulation of
CC       innate and adaptive immunity, and acts as a sensor for proteolytic
CC       enzymes generated during infection. Generally is promoting
CC       inflammation. Can signal synergistically with TLR4 and probably TLR2 in
CC       inflammatory responses and modulates Tlr3 signaling. Has a protective
CC       role in establishing the endothelial barrier; the activity involves
CC       coagulation factor X. Regulates endothelial cell barrier integrity
CC       during neutrophil extravasation, probably following proteolytic
CC       cleavage by PRTN3 (By similarity). Proposed to have a bronchoprotective
CC       role in airway epithelium, but also shown to compromise the airway
CC       epithelial barrier by interrupting E-cadherin adhesion. Involved in the
CC       regulation of vascular tone; activation results in hypotension
CC       presumably mediated by vasodilation. Associates with a subset of G
CC       proteins alpha subunits such as GNAQ, GNA11, GNA14, GNA12 and GNA13,
CC       but probably not with G(o)-alpha, G(i) subunit alpha-1 and G(i) subunit
CC       alpha-2. Believed to be a class B receptor which internalizes as a
CC       complex with arrestin and traffic with it to endosomal vesicles,
CC       presumably as desensitized receptor, for extended periods of time.
CC       Mediates inhibition of TNF-alpha stimulated JNK phosphorylation via
CC       coupling to G GNAQ and GNA11; the function involves dissociation of
CC       RIPK1 and Tradd from TNFR1. Mediates phosphorylation of nuclear factor
CC       NF-kappa-B RELA subunit at 'Ser-536'; the function involves Ikbkb and
CC       is predominantly independent of G proteins. Involved in cellular
CC       migration. Involved in cytoskeletal rearrangement and chemotaxis
CC       through beta-arrestin-promoted scaffolds; the function is independent
CC       of GNAQ and GNA11 and involves promotion of cofilin dephosphorylation
CC       and actin filament severing. Induces redistribution of COPS5 from the
CC       plasma membrane to the cytosol and activation of the JNK cascade is
CC       mediated by Cops5. Involved in the recruitment of leukocytes to the
CC       sites of inflammation and is the major PAR receptor capable of
CC       modulating eosinophil function such as pro-inflammatory cytokine
CC       secretion, superoxide production and degranulation. During inflammation
CC       promotes dendritic cell maturation, trafficking to the lymph nodes and
CC       subsequent T-cell activation. Involved in antimicrobial response of
CC       innate immune cells; activation enhances phagocytosis of Gram-positive
CC       and killing of Gram-negative bacteria. Acts synergistically with
CC       interferon-gamma in enhancing antiviral responses (By similarity).
CC       {ECO:0000250|UniProtKB:P55085, ECO:0000269|PubMed:11884377}.
CC   -!- SUBUNIT: Interacts with TLR4, COPS5 and TMED2. Interacts with GNAQ,
CC       GNA11, GNA12, GNA13 and GNA14 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q63645; Q63524: Tmed2; NbExp=2; IntAct=EBI-4303358, EBI-918600;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass membrane
CC       protein.
CC   -!- PTM: A proteolytic cleavage generates a new N-terminus that functions
CC       as a tethered ligand. Activating serine proteases include trypsin, mast
CC       cell tryptase, coagulation factors VII and Xa, myeloblastin/PRTN3 and
CC       membrane-type serine protease 1/ST14. Proposed subsequent cleavage by
CC       serine proteases is leading to receptor deactivation and include
CC       neutrophil elastase and cathepsin G. At least in part, implicated
CC       proteases are also shown to activate the receptor; the glycosylation
CC       status of the receptor is thought to contribute to the difference.
CC       {ECO:0000250|UniProtKB:P55085}.
CC   -!- PTM: N-glycosylated and sialylated. {ECO:0000250|UniProtKB:P55085}.
CC   -!- PTM: Multiple phosphorylated on serine and threonine residues in the
CC       cytoplasmic region upon receptor activation; required for receptor
CC       desensitization and recruitment of beta-arrestin.
CC   -!- PTM: Monoubiquitinated by Cbl at the plasma membrane and in early
CC       endosomes; not required for receptor endocytosis but for translocation
CC       to late endosomes or lysosomes. Deubiquitination involves Stambp and
CC       Usp8; required for lysosomal trafficking and receptor degradation (By
CC       similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: Synthetic PAR agonist peptides (APs) that mimic the
CC       first six amino acids of the newly formed N-terminus activate the
CC       native, uncleaved receptor nonenzymatically by binding directly to the
CC       corresponding second extracellular loop to mediate signaling.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U61373; AAC52703.1; -; mRNA.
DR   EMBL; BC099765; AAH99765.1; -; mRNA.
DR   RefSeq; NP_446349.1; NM_053897.2.
DR   AlphaFoldDB; Q63645; -.
DR   SMR; Q63645; -.
DR   BioGRID; 250560; 2.
DR   IntAct; Q63645; 2.
DR   STRING; 10116.ENSRNOP00000058298; -.
DR   BindingDB; Q63645; -.
DR   ChEMBL; CHEMBL2429706; -.
DR   GlyCosmos; Q63645; 2 sites, No reported glycans.
DR   GlyGen; Q63645; 2 sites.
DR   PhosphoSitePlus; Q63645; -.
DR   PaxDb; 10116-ENSRNOP00000058298; -.
DR   ABCD; Q63645; 9 sequenced antibodies.
DR   Ensembl; ENSRNOT00000061580.2; ENSRNOP00000058298.1; ENSRNOG00000018003.7.
DR   Ensembl; ENSRNOT00055047845; ENSRNOP00055039388; ENSRNOG00055027614.
DR   Ensembl; ENSRNOT00060051820; ENSRNOP00060043084; ENSRNOG00060029837.
DR   Ensembl; ENSRNOT00065041730; ENSRNOP00065034107; ENSRNOG00065024331.
DR   GeneID; 116677; -.
DR   KEGG; rno:116677; -.
DR   UCSC; RGD:620866; rat.
DR   AGR; RGD:620866; -.
DR   CTD; 2150; -.
DR   RGD; 620866; F2rl1.
DR   eggNOG; ENOG502QR8S; Eukaryota.
DR   GeneTree; ENSGT01050000244840; -.
DR   HOGENOM; CLU_009579_8_2_1; -.
DR   InParanoid; Q63645; -.
DR   OMA; SQSHVYA; -.
DR   OrthoDB; 4075920at2759; -.
DR   Reactome; R-RNO-375276; Peptide ligand-binding receptors.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   PRO; PR:Q63645; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000018003; Expressed in jejunum and 17 other cell types or tissues.
DR   GO; GO:0005769; C:early endosome; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0031143; C:pseudopodium; ISS:UniProtKB.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; ISS:UniProtKB.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; ISS:UniProtKB.
DR   GO; GO:0031681; F:G-protein beta-subunit binding; ISS:UniProtKB.
DR   GO; GO:0002020; F:protease binding; ISO:RGD.
DR   GO; GO:0001648; F:proteinase-activated receptor activity; ISO:RGD.
DR   GO; GO:0015057; F:thrombin-activated receptor activity; IEA:InterPro.
DR   GO; GO:0007596; P:blood coagulation; IEA:InterPro.
DR   GO; GO:0045217; P:cell-cell junction maintenance; ISO:RGD.
DR   GO; GO:0051607; P:defense response to virus; ISS:UniProtKB.
DR   GO; GO:0061028; P:establishment of endothelial barrier; ISO:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0050900; P:leukocyte migration; ISS:UniProtKB.
DR   GO; GO:0070661; P:leukocyte proliferation; ISS:UniProtKB.
DR   GO; GO:0097029; P:mature conventional dendritic cell differentiation; ISS:UniProtKB.
DR   GO; GO:0032682; P:negative regulation of chemokine production; ISO:RGD.
DR   GO; GO:0046676; P:negative regulation of insulin secretion; ISO:RGD.
DR   GO; GO:0046329; P:negative regulation of JNK cascade; ISO:RGD.
DR   GO; GO:0034140; P:negative regulation of toll-like receptor 3 signaling pathway; ISO:RGD.
DR   GO; GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0042119; P:neutrophil activation; ISS:UniProtKB.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0030836; P:positive regulation of actin filament depolymerization; ISO:RGD.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:0032722; P:positive regulation of chemokine production; ISS:UniProtKB.
DR   GO; GO:0050921; P:positive regulation of chemotaxis; ISS:UniProtKB.
DR   GO; GO:0002720; P:positive regulation of cytokine production involved in immune response; ISS:UniProtKB.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISS:UniProtKB.
DR   GO; GO:0043311; P:positive regulation of eosinophil degranulation; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0003104; P:positive regulation of glomerular filtration; IDA:UniProtKB.
DR   GO; GO:0032731; P:positive regulation of interleukin-1 beta production; ISS:UniProtKB.
DR   GO; GO:0032733; P:positive regulation of interleukin-10 production; ISS:UniProtKB.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; ISS:UniProtKB.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; ISS:UniProtKB.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; ISO:RGD.
DR   GO; GO:0002690; P:positive regulation of leukocyte chemotaxis; ISO:RGD.
DR   GO; GO:0070963; P:positive regulation of neutrophil mediated killing of gram-negative bacterium; ISO:RGD.
DR   GO; GO:0060100; P:positive regulation of phagocytosis, engulfment; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISS:UniProtKB.
DR   GO; GO:0050927; P:positive regulation of positive chemotaxis; ISO:RGD.
DR   GO; GO:0031274; P:positive regulation of pseudopodium assembly; ISS:UniProtKB.
DR   GO; GO:1900135; P:positive regulation of renin secretion into blood stream; ISS:UniProtKB.
DR   GO; GO:0035025; P:positive regulation of Rho protein signal transduction; ISS:UniProtKB.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; ISS:UniProtKB.
DR   GO; GO:0034137; P:positive regulation of toll-like receptor 2 signaling pathway; ISO:RGD.
DR   GO; GO:0034141; P:positive regulation of toll-like receptor 3 signaling pathway; ISO:RGD.
DR   GO; GO:0034145; P:positive regulation of toll-like receptor 4 signaling pathway; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0032729; P:positive regulation of type II interferon production; ISS:UniProtKB.
DR   GO; GO:0099109; P:potassium channel activating, G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0030193; P:regulation of blood coagulation; ISO:RGD.
DR   GO; GO:0043122; P:regulation of canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:2000341; P:regulation of chemokine (C-X-C motif) ligand 2 production; ISS:UniProtKB.
DR   GO; GO:0046328; P:regulation of JNK cascade; ISS:UniProtKB.
DR   GO; GO:0002286; P:T cell activation involved in immune response; ISS:UniProtKB.
DR   GO; GO:0042311; P:vasodilation; IDA:GO_Central.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR002281; Pro_rcpt_2.
DR   InterPro; IPR003912; Protea_act_rcpt.
DR   PANTHER; PTHR24232; G-PROTEIN COUPLED RECEPTOR; 1.
DR   PANTHER; PTHR24232:SF21; PROTEINASE-ACTIVATED RECEPTOR 2; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR01428; PROTEASEAR.
DR   PRINTS; PR01152; PROTEASEAR2.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; G-protein coupled receptor; Glycoprotein;
KW   Immunity; Inflammatory response; Innate immunity; Lipoprotein; Membrane;
KW   Palmitate; Phosphoprotein; Receptor; Reference proteome; Signal;
KW   Transducer; Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   PROPEP          26..36
FT                   /note="Removed for receptor activation"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000012754"
FT   CHAIN           37..397
FT                   /note="Proteinase-activated receptor 2"
FT                   /id="PRO_0000012755"
FT   TOPO_DOM        37..71
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P55085"
FT   TRANSMEM        72..101
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:P55085"
FT   TOPO_DOM        102..108
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P55085"
FT   TRANSMEM        109..137
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:P55085"
FT   TOPO_DOM        138..149
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P55085"
FT   TRANSMEM        150..177
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:P55085"
FT   TOPO_DOM        178..183
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P55085"
FT   TRANSMEM        184..211
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:P55085"
FT   TOPO_DOM        212..235
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P55085"
FT   TRANSMEM        236..269
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:P55085"
FT   TOPO_DOM        270..277
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P55085"
FT   TRANSMEM        278..317
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:P55085"
FT   TOPO_DOM        318..323
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P55085"
FT   TRANSMEM        324..347
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:P55085"
FT   TOPO_DOM        348..397
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P55085"
FT   SITE            36..37
FT                   /note="Cleavage; by trypsin"
FT                   /evidence="ECO:0000250"
FT   LIPID           361
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        23
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        222
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        148..226
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
SQ   SEQUENCE   397 AA;  44441 MW;  27DE0C3ACABC798D CRC64;
     MRSLSLAWLL GGITLLAASA SCNRTVNAPG PNSKGRSLIG RLDTPPPITG KGAPVEPGFS
     VDEFSASVLT GKLTTVFLPV IYIIVFVIGL PSNGMALWVF FFRTKKKHPA VIYMANLALA
     DLLSVIWFPL KISYHLHGND WTYGDALCKV LIGFFYGNMY CSILFMTCLS VQRYWVIVNP
     MGHSRKRANI AVGVSLAIWL LIFLVTIPLY VMRQTIYIPA LNITTCHDVL PEEVLVGDMF
     SYFLSLAIGV FLFPALLTAS AYVLMIKTLR SSAMDEHSEK KRRRAIRLII TVLSMYFICF
     APSNVLLVVH YFLIKSQRQS HVYALYLVAL CLSTLNSCID PFVYYFVSKD FRDQARNALL
     CRSVRTVKRM QISLTSNKFS RKSSSYSSSS TSVKTSY
//
